Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06333366
Other study ID # 202301590A0C501
Secondary ID Application No.2
Status Recruiting
Phase N/A
First received
Last updated
Start date February 18, 2024
Est. completion date September 20, 2025

Study information

Verified date March 2024
Source Chang Gung Memorial Hospital
Contact Dong-Ru Ho, MD, PhD
Phone 886-975353211
Email redoxdrh@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PDT is a continuous pressure monitoring for Intra-Abdominal hypertension (IAH) designed to be less invasive than pan-endoscopic evaluation, more tolerable than abdominal tapping, and more effective than intravesical pressure measurement for IAH. The PDT device consists of a piezoelectric sensor module with a low power Bluetooth wireless transmitter encased in biocompatible capsule. The device will be swallowed after activation. Following PDT insertion, the patient is fitted with a custom, removable external waist accessory containing a receiver, which is worn during monitoring and provide PDT location by signal analysis with sufficient information to provide IAH trends.


Description:

The participant will receive first phantom capsule after complete survey before the test, which include standard clinical intra-vesical pressure measurement in the perioperative period of laparoscopic surgery. The phantom capsule is an equal-weighted device of the same outer shell but without the electric circuits. After the phantom capsule has been passed out, the participant will receive the standard PDT capsule to record measured information continuously. The date of the laparoscopic surgery should be within follow-up day 2 to day 6. Standard clinical intra-vesical pressure measurement will only be applied in the perioperative period of laparoscopic surgery. The participant will still be monitored by standard PDT capsule afterwards. After the PDT capsule passed out, the participant will receive complete checkup again for comparison.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date September 20, 2025
Est. primary completion date July 16, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 55 Years
Eligibility Inclusion Criteria: - Patient volunteer planning for laparoscopic surgery - Subjects willing to sign an informed consent form (ICF), - Adult subjects, age = 20 and age = 80 years old - BMI between 15(kg/m2)- 35(kg/m2) - Subjects willing to comply to study protocol requirements (blood pressure measurement, diet, alcohol, study visits, blood sampling, etc.) - Patient who had been scheduled for any laparoscopic surgery which may alter intra-abdominal pressure. - Patient volunteer planning for laparoscopic surgery, as self-declared and confirmed by screening assessments and Principal Investigator's judgment Exclusion Criteria: - Patients with a high risk for capsule retention (such as intestinal diverticula, acute abdominal pain without regular defecation indicating intestinal obstruction or a history of abdominal operation or intestinal reconstructed operation), - Any evidence that occlusion of gastrointestinal tract is obvious or severe paralytic ileus that may result in intra-abdominal hypertension in need of immediate surgical intervention not caused by base of tongue (i.e., central apnea, neurologic disorder, retropalatal collapse, nasal obstruction) - Any condition that subject is expected to undergo MRI examination within 7 days after ingestion of the capsule. - Any factor that, in the surgeon's judgment, would pose a risk to surgery or placement of an intra-gastrointestinal monitoring device - Any factor that, in the surgeon's judgment, would make the subject unlikely to respond to PDT insertion and pressure measurement. - Congenital anomalies of gastrointestinal tract or any other anatomical abnormality of the head, neck, chest, or abdomen that would be a contraindication to placement of the PDT device and usage of the external device - There are no exclusion criteria based on gender, race or ethnicity - Patients with a history of Crohn's disease i* Patients with serious systematic diseases such as congestive heart failure, renal failure or severe liver disease. - Any blood disorder identified by haematocrit <30% or >55% - History of hepatitis B, hepatitis C, or HIV - Subject has had prior abdominal surgery of the gastrointestinal tract other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator - Female subjects who are pregnant, planning on becoming pregnant or nursing - Any disorder, which in the investigator's opinion might jeopardise subject's safety or compliance with the protocol. - Coagulation disorder, wound healing and bleeding disorder or taking anticoagulant medication - The presence of any other active implanted device, such as cardiac pacemaker or other implanted electro medical devices. - The presence of any other wireless sensor or transmitter located in abdomen (excluding compatible device also for pressure sensing and other location is acceptable) - Impaired fasting glucose or impaired glucose tolerance (for Patient volunteer planning for laparoscopic surgery) - Any contraindication to the use of the PDT system as listed in the device Instructions for Use (IFU) (i.e. any known allergy to PDMS) - Subject has dysphagia

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intra-gastrointestinal monitoring device (PDT)
The PressureDOT(PDT) is an active intra-gastrointestinal device, that is intended to be introduced in the gastrointestinal tract, approximately along whole. The device is battery powered. The signal is wirelessly transmitted through outside the body and received by waist receiver, using an antenna array applied to the skin with a protection guard at the level of the abdomen.

Locations

Country Name City State
Taiwan Dong-Ru Ho Chiayi City

Sponsors (2)

Lead Sponsor Collaborator
Chang Gung Memorial Hospital DOTSPACE

Country where clinical trial is conducted

Taiwan, 

References & Publications (2)

Liao CH, Cheng CT, Chen CC, Jow UM, Chen CH, Lai YL, Chen YC, Ho DR. An Ingestible Electronics for Continuous and Real-Time Intraabdominal Pressure Monitoring. J Pers Med. 2020 Dec 24;11(1):12. doi: 10.3390/jpm11010012. — View Citation

Liao CH, Cheng CT, Chen CC, Wang YH, Chiu HT, Peng CC, Jow UM, Lai YL, Chen YC, Ho DR. Systematic Review of Diagnostic Sensors for Intra-Abdominal Pressure Monitoring. Sensors (Basel). 2021 Jul 15;21(14):4824. doi: 10.3390/s21144824. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Rate of sensor ability to measure intra-gastrointestinal pressure (IGP) to allow the development of the algorithm workup for correlation 5 days
Other Incidence of influence of interference substances (i.e. water, saliva, gastric juice, bile, intestinal secretion, feces, and food debris ) evaluating feasibility of working condition 7 days
Primary Incidence of device-related or sensor insertion/removal procedure-related adverse events evaluating of incidence of adverse event (AE) 15 days
Primary Rate of foreign body reaction due intra-gastrointestinal insertion evaluating GI symptoms 15 days
Primary Rate of GI symptoms, i.e. inflammation, infection, diarrhea, bowel obstruction, and ileus evaluating safety 15 days
Primary Incidence of sensor failure evaluating stability of device 15 days
Secondary Percentage of users feedback in the form of clinical questionnaire to assess the 'easiness' of insertion procedure with questionnaire evaluating feed back 1 day
Secondary Duration of PDT insertion and explantation procedure monitoring usability needs 15 days
Secondary Incidence of side effects in Post explantation follow-up follow up for sequel 30 days
Secondary Rate of GI dysfunction after 10 days post explantation of the PDT sensor. Follow-up via phone call after 30 days monitoring of GI symptoms 30 days
See also
  Status Clinical Trial Phase
Completed NCT01507766 - The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis Phase 4
Completed NCT03567265 - Intra-abdominal Hypertension and Associated Factors Among Patients Admitted in Intensive Care Units in Uganda.
Completed NCT02514135 - Intra-abdominal Hypertension in Critically Ill Patients
Completed NCT02543658 - Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension Phase 2
Recruiting NCT01825304 - The Study of Using Esophageal Pressure to Guide the PEEP Setting in Abdominal Hypertension Patients Who Undergoing Mechanical Ventilation Phase 4
Recruiting NCT02944292 - Effect of Sedation on Intra-abdominal Pressure Phase 4
Not yet recruiting NCT03670771 - Intraabdominal Pressure in Critically Ill Patients
Not yet recruiting NCT03876418 - Surveillance, Prevention and Treatment of Intra-abdominal Hypertension and Abdominal Compartment Syndrome N/A
Not yet recruiting NCT04286490 - Prone Position and Renal Resistive Index N/A
Completed NCT01355094 - Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury N/A
Not yet recruiting NCT02814734 - Abdominal Compartment Syndrome : Diagnostic and Prognostic Value of CT Findings - a Prospective Study N/A
Recruiting NCT04463745 - Organ Dysfunction Associated With Intra Abdominal Pressures in Liver Transplantation
Completed NCT00747552 - Intra-Abdominal Hypertension in Neonatal Intensive Care Patients N/A
Completed NCT05732545 - Application of Enteral Nutrition Program in Patients With Intra-abdominal Hypertension Oriented by Intra-abdominal Pressure N/A
Enrolling by invitation NCT05070572 - Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output
Completed NCT04481880 - Correlation of Intra-abdominal Pressure With Gastric and Urinary Bladder Pressures in Patients With Morbid Obesity
Recruiting NCT01072071 - The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients N/A
Withdrawn NCT01077895 - The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function Phase 3
Completed NCT04525027 - Predictive Ability of Intra-Abdominal Pressure for Mortality in Patients With Severe Acute Pancreatitis
Not yet recruiting NCT06160856 - Correlation of Ultrasonography Indices of Venous Congestion With Intra-abdominal Pressure in ICU Patients.